Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.

• Status: Recruiting
• Trial end date: 2022-12-10
• Target enrollment: 0
• Participant gender: Female

Summary

The use of intrauterine device (IUD) in Brazil is still not very significant and one of the reasons is the fear of feeling pain during its insertion procedure. Articaine is an amide-linked local anesthetic, its plasma half-life is shorter than that of most other amide-type anesthetics, which makes it theoretically favorable in relation to systemic toxicity.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Universidade do Vale do Sapucai
• Treatments: Carticaine; Mepivacaine

Criteria

Inclusion Criteria:

• Female patients, aged between 20 and 40 years

Exclusion Criteria:

• Diabetes (type I or II)

• Chronic Kidney

• Urogenital infections

• Psychiatric disesas

• Surgery during the study period